Abstract
To explore the effects of CYP19A1 gene polymorphisms, plasma zinc, and urinary zinc levels and their interactions on type 2 diabetes mellitus (T2DM) in residents of Gongcheng County, Guangxi, China. The case–control study was used for the investing. The MassARRAY System was applied to genotype the CYP19A1 genes rs752760, rs10046, rs10459592, and rs700518 in 540 study subjects. Plasma and urinary zinc concentrations were measured by inductively coupled plasma mass spectrometry (ICP-MS). Conditional logistic regression showed that rs752760 and plasma zinc were associated with T2DM risks with ORs of 0.593 (95% CI: 0.371–0.948) and 0.563 (95% CI: 0.356–0.889), respectively. Unconditional logistic regression analysis showed an association between urinary zinc levels and the risk of T2DM as well, with an OR of 0.352 (95% CI: 0.212–0.585). The results of the multiplicative interaction model showed that the rs752760 T allele was associated with a significantly reduced risk of T2DM with moderate/low plasma zinc levels, with ORs of 0.340 (95% CI: 0.161–0.715) and 0.583 (95% CI: 0.346–0.981), respectively, and the rs752760 T allele was also associated with a significantly decreased risk of T2DM with moderate/low urinary zinc levels, with ORs of 0.358 (95% CI: 0.201–0.635) and 0.321 (95% CI: 0.183–0.562), respectively. CYP19A1 rs752760 T allele and moderate/low plasma/urinary zinc levels reduce the risk of T2DM.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are not publicly available due to [REASON(S) WHY DATA ARE NOT PUBLIC] but are available from the corresponding authors on reasonable request.
References
Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet 389(10085):2239–2251
Zimmet P, Alberti KG, Magliano DJ, Bennett PH (2016) Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 12(10):616–622
Fernández-Cao JC, Warthon-Medina M, Arija HMVV, Doepking C, Serra-Majem L, Lowe NM (2019) Zinc intake and status and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Nutrients 11(5):1027
Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88–98
Bao XY, Peng B, Yang MS (2012) Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Mol Biol Rep 39(3):2447–2454
Flores CR, Puga MP, Wrobel K, GaraySevilla ME, Wrobel K (2011) Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications. Diabetes Res Clin Pract 91(3):333–41
Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F (2008) Global complication rates of type 2 diabetes in Indigenous peoples: a comprehensive review. Diabetes Res Clin Pract 82(1):1–17
Doddigarla Z, Parwez I, Ahmad J (2016) Correlation of serum chromium, zinc, magnesium and SOD levels with HbA1c in type 2 diabetes: a cross sectional analysis. Diabetes Metab Syndr 10(1 Suppl 1):S126–S129
Kato N (2013) Insights into the genetic basis of type 2 diabetes. J Diabetes Investig 4(3):233–244
Hosseini E, Shahhoseini M, Afsharian P, Karimian L, Ashrafi M, Mehraein F, Afatoonian R (2019) Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome. Arch Med Sci 15(4):887–895
Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264(32):19385–19391
Xu WH, Dai Q, Xiang YB, Long JR, Ruan ZX, Cheng JR, Zheng W, Shu XO (2007) Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 166(12):1420–1430
Travis RC, Schumacher F, Hirschhorn JN, Kraft P, Allen NE, Albanes D, Berglund G, Berndt SI, Boeing H, Bueno-de-Mesquita HB, Calle EE, Chanock S, Dunning AM, Hayes R, Feigelson HS, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Kaaks R, Kolonel LN, Ma J, Rodriguez L, Riboli E, Stampfer M, Stram DO, Thun MJ, Tjønneland A, Trichopoulos D, Vineis P, Virtamo J, Le Marchand L, Hunter DJ (2009) CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomark Prev 18(10):2734–2744
Long JR, Kataoka N, Shu XO, Wen W, Gao YT, Cai Q, Zheng W (2006) Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. Cancer Epidemiol Biomark Prev 15(11):2115–2122
Kamiński A, Bogacz A, Górska-Paukszta M, Seremak-Mrozikiewicz A, Czerny B (2019) Correlation of rs749292 and rs700518 polymorphisms in the aromatase gene (CYP19A1) with osteoporosis in postmenopausal Polish women. Adv Clin Exp Med 28(8):1067–1071
Tsuchiya N, Wang L, Suzuki H, Segawa T, Fukuda H, Narita S, Shimbo M, Kamoto T, Mitsumori K, Ichikawa T, Ogawa O, Nakamura A, Habuchi T (2006) Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer. J Clin Oncol 24(13):1982–1989
Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, Clavel-Chapelon F, Colditz GA, Cox DG, Feigelson HS, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn JN, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Le Marchand L, Lenner P, Lund E, Panico S, Peeters PH, Pike MC, Riboli E, Tjonneland A, Travis R, Trichopoulos D, Wacholder S, Ziegler RG (2007) Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67(5):1893–1897
Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304(1–2):63–68
Barros RP, Morani A, Moriscot A, Machado UF (2008) Insulin resistance of pregnancy involves estrogen-induced repression of muscle GLUT4. Mol Cell Endocrinol 295(1–2):24–31
Meyer JA, Spence DM (2009) A perspective on the role of metals in diabetes: past findings and possible future directions. Metallomics 1(1):32–41
Moore WT, Bowser SM, Fausnacht DW, Staley LL, Suh KS, Liu D (2015) Beta cell function and the nutritional state: dietary factors that influence insulin secretion. Curr Diab Rep 15(10):76
Nishi Y (1996) Zinc and growth. J Am Coll Nutr 15(4):340–344
Bedwal RS, Bahuguna A (1994) Zinc, copper and selenium in reproduction. Experientia 50(7):626–640
Om AS, Chung KW (1996) Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver. J Nutr 126(4):842–848
Maremanda KP, Srivalliputturu SB, Jena G (2020) Zinc deficient diet exacerbates the testicular and epididymal damage in type 2 diabetic rat: studies on oxidative stress-related mechanisms. Reprod Biol 20(2):191–201
Ranasinghe P, Wathurapatha WS, Galappatthy P, Katulanda P, Jayawardena R, Constantine GR (2018) Zinc supplementation in prediabetes: a randomized double-blind placebo-controlled clinical trial. J Diabetes 10(5):386–397
Yin J, Wang X, Li S, Zhu Y, Chen S, Li P, Luo C, Huang Y, Li X, Hu X, Yang W, Bao W, Shan Z, Liu L (2019) Interactions between plasma copper concentrations and SOD1 gene polymorphism for impaired glucose regulation and type 2 diabetes. Redox Biol 24:101172
Xu M, Cai J, Mo X, Liu Q, Zhang J, Wei Y, Liu S, Lin Y, Huang S, Mo C, Mai T, Tan D, Zhang Z, Qin J (2022) Association of dietary and plasma magnesium with glycaemic markers in a Chinese population. Biol Trace Elem Res
Mo X, Cai J, Lin Y, Liu Q, Xu M, Zhang J, Liu S, Wei C, Wei Y, Huang S, Mai T, Tan D, Lu H, Luo T, Gou R, Zhang Z, Qin J (2021) Correlation between urinary contents of some metals and fasting plasma glucose levels: a cross-sectional study in China. Ecotoxicol Environ Saf 228:112976
Coban N, Onat A, Guclu-Geyik F, Can G, Erginel-unaltuna N (2015) sex- and obesity-specific association of aromatase (CYP19A1) gene variant with apolipoprotein b and hypertension. Arch Med Res 46(7):564–571
Yang Y, Wang P (2020) Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population. Lipids Health Dis 19(1):187
Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD et al (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15(3):342–355
Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57(3):359–383
Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M (2003) The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol 86(3–5):219–224
Eriksson AL, Lorentzon M, Vandenput L, Labrie F, Lindersson M, Syvänen AC, Orwoll ES, Cummings SR, Zmuda JM, Ljunggren O, Karlsson MK, Mellström D, Ohlsson C (2009) Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94(3):1033–1041
Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013) The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34(3):309–338
Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A, Dehghan A, Kavousi M, Laven JS, Franco OH (2017) Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes 66(3):577–586
Yeung EH, Zhang C, Mumford SL, Ye A, Trevisan M, Chen L, Browne RW, Wactawski-Wende J, Schisterman EF (2010) Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab 95(12):5435–5442
Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295(11):1288–1299
Zha W, Ho HTB, Hu T, Hebert MF, Wang J (2017) Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance. Sci Rep 7(1):1137
Li XT, Yu PF, Gao Y, Guo WH, Wang J, Liu X, Gu AH, Ji GX, Dong Q, Wang BS, Cao Y, Zhu BL, Xiao H (2017) Association between plasma metal levels and diabetes risk: a case-control study in China. Biomed Environ Sci 30(7):482–491
Shan Z, Bao W, Zhang Y, Rong Y, Wang X, Jin Y, Song Y, Yao P, Sun C, Hu FB, Liu L (2014) Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes. Diabetes 63(5):1796–1803
Yary T, Virtanen JK, Ruusunen A, Tuomainen TP, Voutilainen S (2016) Serum zinc and risk of type 2 diabetes incidence in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. J Trace Elem Med Biol 33:120–124
Siddiqui K, Bawazeer N, Joy SS (2014) Variation in macro and trace elements in progression of type 2 diabetes. ScientificWorldJournal 2014:461591
Skalnaya MG, Skalny AV, Tinkov AA (2017) Serum copper, zinc, and iron levels, and markers of carbohydrate metabolism in postmenopausal women with prediabetes and type 2 diabetes mellitus. J Trace Elem Med Biol 43:46–51
Bunce GE, Vessal M (1987) Effect of zinc and/or pyridoxine deficiency upon oestrogen retention and oestrogen receptor distribution in the rat uterus. J Steroid Biochem 26(3):303–308
Sunar F, Gormus ZI, Baltaci AK, Mogulkoc R (2008) The effect of low dose zinc supplementation to serum estrogen and progesterone levels in post-menopausal women. Biol Trace Elem Res 126(Suppl 1):S11–S14
Denier X, Hill EM, Rotchell J, Minier C (2009) Estrogenic activity of cadmium, copper and zinc in the yeast estrogen screen. Toxicol In Vitro 23(4):569–573
Qi L, Hu FB, Hu G (2008) Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med 8(6):519–532
Acknowledgements
We are deeply appreciative of the participants in this study, and we thank all the staff for their support and assistance.
Funding
The study was supported by the National Natural Science Foundation of China (Grant Nos. 81960583, 81760577, 81560523, and 82260629), Major Science and Technology Projects in Guangxi (AA22096026), the Guangxi Science and Technology Development Project (Grant Nos. AD 17129003 and 18050005), the Guangxi Natural Science Foundation for Innovation Research Team (2019GXNSFGA245002), and the Guangxi Scholarship Fund of Guangxi Education Department of China.
Author information
Authors and Affiliations
Contributions
Xuexiu Wang analyzed the data and wrote the manuscript. Yujian Liang, Qiumei Liu, and Jiansheng Cai revised the manuscript and gave suggestions. Xu Tang, Shuzhen Liu, Junling Zhang, Min Xu, Chunmei Wei, Xiaoting Mo, Yanfei Wei, Yinxia Lin, Shenxiang Huang, Tingyu Mai, Dechan Tan, Tingyu Luo, and Ruoyu Gou collected the relevant data. Jian Qin and Zhiyong Zhang put forward the study topic and provided advice on the writing of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
Approval was obtained from the ethics committee of Guilin Medical University (No. 20180702–3). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
Consent to Participate
Written informed consent files were received from all participants before the study.
Consent for Publication
The participant has consented to the submission of the case report to the journal.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, X., Liang, Y., Liu, Q. et al. Association of CYP19A1 Gene, Plasma Zinc, and Urinary Zinc with the Risk of Type 2 Diabetes Mellitus in a Chinese Population. Biol Trace Elem Res 201, 4205–4215 (2023). https://doi.org/10.1007/s12011-022-03502-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-022-03502-1